---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296110382.md"
description: "HUTCHMED shares are trading higher after the company announced high-level results from the SAFFRON Phase III trial."
datetime: "2026-08-17T12:35:55.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296110382.md)
  - [en](https://longbridge.com/en/news/296110382.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296110382.md)
---

# 

HUTCHMED shares are trading higher after the company announced high-level results from the SAFFRON Phase III trial.

### Related Stocks

- [HCM.US](https://longbridge.com/en/quote/HCM.US.md)
- [00013.HK](https://longbridge.com/en/quote/00013.HK.md)

## Related News & Research

- [REG - Hutchmed China Ltd - Announcement pursuant to AIM Rule 17 Schedule 2(g)](https://longbridge.com/en/news/296201366.md)
- [HUTCHMED (NASDAQ:HCM) Shares Gap Down   - Here's Why](https://longbridge.com/en/news/296383116.md)
- [Dynamix Corp III (NASDAQ:DNMX) Sees Significant Increase in Short Interest](https://longbridge.com/en/news/295928780.md)
- [National Healthcare Properties director Albert M. Campbell III files initial beneficial ownership statement](https://longbridge.com/en/news/296401234.md)
- [Business First Bancshares director George W. Cummings III sells 10,000 shares for $317,800](https://longbridge.com/en/news/296397929.md)